Highlights the need for renewed efforts to improve the quality of care and outcomes for patients with diabetes mellitus presenting with acute coronary syndromes.
Persistent treatment gaps in high-risk diabetic ACS patients support targeted quality initiatives and further implementation research.
Patients with diabetes mellitus who present with acute ST-segment elevation myocardial infarction or non-ST-segment elevation acute coronary syndromes have a higher risk of adverse outcomes than patients without diabetes, and appear to derive greater benefit from evidence-based therapies. However, patients with diabetes mellitus are less commonly treated with proven therapies, so renewed efforts are needed to improve the quality of care and outcomes for patients with diabetes mellitus who present with acute coronary syndromes.
No takes yet. Share an insight, caveat, or question.
Trichon et al. (2004) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: